The purpose of this study is to compare the efficacy and tolerability of zotepine versus Risperidone in aggressive schizophrenic patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
39
Oral
Oral
Unnamed facility
Bali, Taipei, Taiwan
Unnamed facility
Taipei, Taiwan
Unnamed facility
Taipei, Taiwan
Unnamed facility
Taoyuan District, Taiwan
Change from baseline in aggression behavior assessed using the Positive and Negative Syndrome Scale Excited Component (PANSS-EC) score.
Time frame: 6 Weeks
Change from baseline on the total score of Positive and Negative Syndrome Scale
Time frame: 6 Weeks
Change from baseline on Clinical Global Impression (CGI)
Time frame: 6 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.